Viewpoint Molecular Targeting Logo

Viewpoint Molecular Targeting develops pharmaceutical drugs for diagnostic imaging and therapy for cancer, with a focus on metastatic melanoma. Their novel image-guided therapies enable a personalized approach to select patients that can benefit most and to optimize treatment planning for targeted therapies.

Back to Top